SAN DIEGO, June 02, 2025 -- BioAtla, Inc. (Nasdaq: BCAB) (the “Company”), a global clinical-stage biotechnology company focused on the development of Conditionally Active Biologic (CAB) antibody therapeutics for the...
Barry Myers will be speaking on a panel discussing financing mechanisms for emerging companies at the Life Sciences Summit 2011 in New York on November 16.
News | 11. 11. 2011
